This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1997 Feb;24(2):248-9.

doi: 10.1093/clinids/24.2.248.

Making antifungal susceptibility testing a clinically useful tool

PMID: 9114155
DOI: 10.1093/clinids/24.2.248

Editorial

Making antifungal susceptibility testing a clinically useful tool

A M Sugar. Clin Infect Dis. 1997 Feb.

. 1997 Feb;24(2):248-9.

doi: 10.1093/clinids/24.2.248.

Author

PMID: 9114155
DOI: 10.1093/clinids/24.2.248

No abstract available

PubMed Disclaimer

Comment on

Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards.
Rex JH, Pfaller MA, Galgiani JN, Bartlett MS, Espinel-Ingroff A, Ghannoum MA, Lancaster M, Odds FC, Rinaldi MG, Walsh TJ, Barry AL. Rex JH, et al. Clin Infect Dis. 1997 Feb;24(2):235-47. doi: 10.1093/clinids/24.2.235. Clin Infect Dis. 1997. PMID: 9114154 Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems